Cytomegalovirus pneumonitis is a risk for bronchiolitis obliterans syndrome in lung transplantation.
about
Cytomegalovirus-induced immunopathology and its clinical consequencesThe lung microbiome after lung transplantationOverview of clinical lung transplantationEfficacy of extracorporeal photopheresis in clearance of antibodies to donor-specific and lung-specific antigens in lung transplant recipients.Infections in the immunosuppressed hostT-bet:Eomes balance, effector function, and proliferation of cytomegalovirus-specific CD8+ T cells during primary infection differentiates the capacity for durable immune control.Polyfunctional cytomegalovirus-specific immunity in lung transplant recipients receiving valganciclovir prophylaxis.Lower incidence of CMV infection and acute rejections with valganciclovir prophylaxis in lung transplant recipientsPrimary cytomegalovirus phosphoprotein 65-specific CD8+ T-cell responses and T-bet levels predict immune control during early chronic infection in lung transplant recipients.A Prospective Monitoring Study of Cytomegalovirus Infection in Non-Immunosuppressed Critical Heart Surgery PatientsIncidence, Risk Factors and Outcomes of Delayed-onset Cytomegalovirus Disease in a Large Retrospective Cohort of Lung Transplant Recipients.IL-12-Dependent Cytomegalovirus-Specific CD4+ T Cell Proliferation, T-bet Induction, and Effector Multifunction during Primary Infection Are Key Determinants for Early Immune Control.Polyfunctional T-Cell Signatures to Predict Protection from Cytomegalovirus after Lung TransplantationSignificance of and risk factors for the development of central airway stenosis after lung transplantation.Early plasma soluble receptor for advanced glycation end-product levels are associated with bronchiolitis obliterans syndromeColonization with small conidia Aspergillus species is associated with bronchiolitis obliterans syndrome: a two-center validation studyHigh-quality CMV-specific CD4+ memory is enriched in the lung allograft and is associated with mucosal viral controlPractical guidelines: lung transplantation in patients with cystic fibrosis.Is prevention the best treatment? CMV after lung transplantation.Lung transplant infection.Chronic lung allograft dysfunction after lung transplantation: the moving target.Leflunomide as part of the treatment for multidrug-resistant cytomegalovirus disease after lung transplantation: case report and review of the literature.Cytomegalovirus Immunoglobulin After Thoracic Transplantation: An OverviewInfectious Triggers of Chronic Lung Allograft Dysfunction.Airway remodelling in the transplanted lung.Analysis of pulmonary non-tuberculous mycobacterial infections after lung transplantation.Clinical characteristics and outcomes of pediatric patients with CMV DNA detection in bronchoalveolar lavage fluid.Sequence homology between HLA-bound cytomegalovirus and human peptides: A potential trigger for alloreactivity.Risk factors, survival, and impact of prophylaxis length in cytomegalovirus-seropositive lung transplant recipients: A prospective, observational, multicenter study.Is human cytomegalovirus infection associated with essential hypertension? A meta-analysis of 11,878 participants.High CXCL-16 levels correlate with symptomatic disease in lung transplant recipients with human cytomegalovirus replication in the allograft.Cytomegalovirus disease in lung transplantation: impact of recipient seropositivity and duration of antiviral prophylaxis.Human cytomegalovirus infection in lung transplant recipients triggers a CXCL-10 response.Prospective analysis of human cytomegalovirus DNAemia and specific CD8+ T cell responses in lung transplant recipients.Cytomegalovirus infection in living-donor and cadaveric lung transplantations.Distal airway microbiome is associated with immunoregulatory myeloid cell responses in lung transplant recipients.Controlling Cytomegalovirus in the Age of Personalized Medicine.Effect of HMG CoA reductase inhibitors on the development of chronic lung allograft dysfunction.Editorial Commentary: Chronic Lung Allograft Dysfunction in Lung Transplant Recipients: Another Piece of the Puzzle.Prolonged Mechanical Ventilation After Lung Transplantation-A Single-Center Study.
P2860
Q21195897-E0FE701A-CD01-4564-8C7C-5D90429DAEB3Q26825397-88410F80-C9D2-47A4-97E1-265AA5CC551BQ28661021-D8F20513-8927-4C66-9F5E-8A5826CCE643Q34036197-1D76039E-54C0-48A6-9816-EB216504D877Q34357428-295C4594-9113-4357-B880-D618E1CC7FEAQ34550760-B7110BBE-2547-43C9-8CDC-333D69761988Q34605186-0FD3C433-004B-4DEB-8E7D-24664D403678Q35064406-FAB25D58-3A28-491D-99AE-4187AABF544DQ35463623-A0F98A5A-6373-4830-8441-B1A3D56C22D5Q35662356-0C8EB3FE-34C4-42E1-AF5F-84444771B939Q35946563-7B873497-19D6-4479-9AD3-49E72DC56D3EQ36447548-141B558F-2CA2-44B2-9E82-5409DF1E74BEQ36516505-B23814FB-2FBD-42DF-AE2D-277C81CCD4FEQ36572613-1CA27F49-D7AA-4226-818C-6F70F86ED64DQ36640118-1604A294-6A69-44CE-A814-A9F53E0F9B4DQ36745407-E5048928-5A44-444E-9676-F226C4535061Q37308147-313282EF-E4BA-4B69-BD99-050909070D42Q37706330-5A1EE2A4-164E-4F81-9ED4-B48727976FF1Q37954420-4CA2C3A1-0004-4F6D-8BFE-E4D1583C88F7Q38010486-FBF4CD4F-3975-495A-8B33-1B77C6EB3107Q38058746-F0088542-C8B6-4932-AF74-A678D65A42E9Q38168278-32137DDE-8A71-4991-86A7-D9C265ED6DFEQ38599972-D0A209F5-0791-459F-BAC1-62287A5DD5C3Q38843601-B2E2901B-35CC-433B-BB70-BBF567EC28CCQ39006011-252241DD-AA32-4362-B5D2-36538753235FQ39638382-68073790-ED2B-4B31-AFD7-3975B6A504BDQ39697350-E0C2E456-C82D-41BB-A3AE-265CFD767652Q40096975-AAB2A2A8-D370-4F5F-904F-EE1D2725A8A3Q40293836-F8A4D9E8-C486-41B9-B301-301A8E376025Q40985239-73E20F62-1C5D-41CA-9508-6E85928E07EDQ42198626-57CE6CB3-A160-4FF9-BA83-F376BDE9BF2DQ42283057-DF28B4F5-6D41-446D-8942-EFFAD32CEFF8Q43536491-EFFF3C0F-6AFE-440B-8C51-29E8EA8F7062Q43909393-0E68DB4B-657F-4961-A8C8-EEF5BE3FB070Q47239011-1AC0CD66-9E4E-4F19-83B7-5FAFDE95F538Q48013021-48E4CE9E-FC8D-4504-A194-6E82F328DE41Q48270925-7BB7E69B-297C-46E0-830C-01E5007144CDQ48277199-6BCDBFC6-456B-47D4-BE07-AF99499B902BQ50939527-7557F79F-C46B-4597-98AC-BFA2B0E05217Q51570793-09198237-8B26-4051-9E1B-F4E460244B8F
P2860
Cytomegalovirus pneumonitis is a risk for bronchiolitis obliterans syndrome in lung transplantation.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cytomegalovirus pneumonitis is ...... drome in lung transplantation.
@ast
Cytomegalovirus pneumonitis is ...... drome in lung transplantation.
@en
type
label
Cytomegalovirus pneumonitis is ...... drome in lung transplantation.
@ast
Cytomegalovirus pneumonitis is ...... drome in lung transplantation.
@en
prefLabel
Cytomegalovirus pneumonitis is ...... drome in lung transplantation.
@ast
Cytomegalovirus pneumonitis is ...... drome in lung transplantation.
@en
P2093
P2860
P921
P1476
Cytomegalovirus pneumonitis is ...... ndrome in lung transplantation
@en
P2093
C Ashley Finlen-Copeland
Daniel A Willner
David Howell
Scott M Palmer
W Jackson Turbyfill
P2860
P304
P356
10.1164/RCCM.200911-1786OC
P407
P577
2010-02-18T00:00:00Z